Alnylam Pharmaceuticals Stock Analysis Archives - Real News Hub

Alnylam Pharmaceuticals stock analysis

Alnylam stock maintains Buy rating at H.C. Wainwright on strong TTR data

Alnylam Pharmaceuticals (NASDAQ: ALNY) has received a reaffirmed Buy rating from H.C. Wainwright, with a price target of $570.00, driven by compelling Phase 3 ...

|